ETFS Holding Novo Nordisk A/S

 
ETFS Holding Novo Nordisk A/S top ^
  • Holdings: Top Holdings AXHE More..., Roche Holding AG, Novartis AG, Sanofi, GlaxoSmithKline PLC, Novo Nordisk A/S
  • Category: Health
Sign-up for axhe investment picks
  • Holdings: Top Holdings EDEN More..., Novo Nordisk A/S, Danske Bank AS, Carlsberg AS, Ap Moeller Maersk A/S B Common Stock Dkk1000., Coloplast
  • Category: Miscellaneous Region
Sign-up for eden investment picks
  • Holdings: Top Holdings GXF More..., Novo Nordisk A/S ADR, LM Ericsson Telephone Company ADR, Hennes & Mauritz AB, Nordea Bank AB, Swedbank AB
  • Category: Miscellaneous Region
Sign-up for gxf investment picks

 
Stock Quotes for Novo Nordisk A/S top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Morningstar Rating: 4 Stars
Sign-up for nvo investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Cyclical
Sign-up for novb investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Morningstar Rating: 4 Stars
Sign-up for novo%20b investment picks
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
Sign-up for 0md0 investment picks

 
News Articles for Novo Nordisk A/S top ^
2013/2/19
Novo Nordisk celebrates 90 years of diabetes innovation Canada NewsWire Global leader in diabetes care recognizes anniversary of Canadian roots MISSISSAUGA, ON, Feb.
Sign-up for Novo Nordisk celebrates 90 years of diabetes innovation investment picks
2013/1/31
PRINCETON, N.J. , Jan.
Sign-up for Novo Nordisk Promotes Four Members of U.S. Leadership Team to Senior Vice President investment picks
2013/2/11
MADRID (MarketWatch) -- Shares of Novo Nordisk AS NVO sank 14% in European trading on Monday.
Sign-up for PULSE: Novo Nordisk sinks 14% on disappointing drug news investment picks
2013/4/19
Diabetes leader bolsters presence in N.J. with 731,000-square-foot office building in Plainsboro, N.J. PLAINSBORO, N.J. , April 19, 2013 /PRNewswire/ -- Advancing its commitment to patients and New Jersey , Novo Nordisk (NYSE: NVO) today unveiled its new U.S. headquarters.
Sign-up for Novo Nordisk Unveils New U.S. Headquarters investment picks
2013/4/29
ROSELAND, N.J., April 29, 2013 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that it has agreed with Novo Nordisk A/S (NYSE:NVO) to amend the two companies' Development and License Agreement to develop and commercialize oral formulations of Novo Nordisk's proprietary GLP-1 receptor agonists, which have the potential of treating Type 2 diabetes, using Emisphere's Eligen ® technology (the "Oral GLP-1 Development Agreement"). Under the terms of the amendment, Novo Nordisk will pay to Emisphere $10 million as a prepayment of development milestone payments that would have otherwise become payable to Emisphere under the Oral GLP-1 Development Agreement upon the initiation of Phase II and Phase III testing of an oral GLP-1 product by Novo Nordisk, in exchange for a reduction in the rate of potential future royalty payments arising from future sales of an oral GLP-1 product developed under the Oral GLP-1 Development Agreement.
Sign-up for Emisphere Announces Amendment to Oral GLP-1 Development License Agreement With Novo Nordisk investment picks
2013/5/1
COPENHAGEN --
Sign-up for Novo Nordisk Net Profit Up As Insulin Sales Surge investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Novo Nordisk A/S
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Novatek Microelectronics Corp.  |  Next: ETFS Holding Novozymes